Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zillion is a digital health company that provides a highly scalable patient engagement platform designed to drive behavioral change and improve health outcomes. The company's technology enables healthcare providers and insurers to deliver personalized, longitudinal care programs for conditions such as obesity, diabetes, and mental health. By integrating live video, digital messaging, and automated content delivery, Zillion facilitates continuous interaction between patients and their care teams. The platform is notably used to power large-scale wellness initiatives, including UnitedHealthcare's Real Appeal program. In late 2021, Zillion was acquired by Amwell to bolster its automated care and digital therapeutics portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zillion Health.